Can a history of “thick blood” confirm true hyperviscosity?

True hyperviscosity is a measurable rheologic abnormality, not a diagnosis established by a subjective feeling or historical label. In a 77-year-old, confirming the underlying mechanism matters because cellular and plasma-protein causes require different evaluation and management.

Clinical and diagnostic evidence

• Excess cellular content is an established cause of whole-blood hyperviscosity. Hematocrit is the dominant contributor, with viscosity rising disproportionately once hematocrit exceeds roughly 50%. Marked leukocytosis—particularly rigid blast cells—can also obstruct microvascular flow.
• Elevated plasma macromolecules are an independent cause. Monoclonal immunoglobulins, especially high-molecular-weight IgM, can markedly increase serum/plasma viscosity; fibrinogen raises plasma viscosity and promotes red-cell aggregation.
• “Thick blood” sensations, headache, or dizziness alone are nonspecific. More concerning manifestations include mucosal bleeding, visual/retinal disturbances, and neurologic symptoms. Objective assessment should distinguish cellular from protein-mediated causes: CBC with hematocrit and platelet count; protein studies including total protein, albumin, immunoglobulins and electrophoresis; fibrinogen when relevant; and serum/plasma viscosity when paraproteinemia is suspected. Whole-blood viscosity may better reflect cellular mechanisms.

Cerebral-flow and mechanistic evidence

• Controlled animal studies show that experimentally increased viscosity can reduce cortical blood flow and oxygen delivery. The effect becomes more consequential when cerebrovascular reserve is limited—e.g., impaired carotid supply—or when oxygen demand/flow requirements increase.
• Autoregulatory vasodilation can preserve resting cerebral flow in some settings, so impaired flow is context-dependent. Human stroke studies associate higher whole-blood viscosity with larger perfusion lesions and ischemic cores, but do not isolate viscosity from hematocrit, fibrinogen, stenosis, and stroke severity.
• Beyond cell number, reduced red-cell deformability and low-shear red-cell aggregation increase flow resistance; fibrinogen contributes to the latter.

Bottom line

• True hyperviscosity can arise from excess cells or plasma proteins and may compromise cerebral microcirculation, particularly with limited vascular reserve. A history of “thick blood” cannot establish either the condition or its cause without targeted laboratory assessment; urgent bleeding, visual, or focal neurologic symptoms warrant prompt specialist evaluation.